GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
3.000
-0.180 (-5.66%)
At close: Mar 28, 2024, 4:00 PM
3.060
+0.060 (2.00%)
After-hours: Mar 28, 2024, 7:37 PM EDT
GlycoMimetics Market Cap
GlycoMimetics has a market cap or net worth of $193.18 million as of March 28, 2024. Its market cap has increased by 167.19% in one year.
Market Cap
193.18M
Enterprise Value
152.20M
1-Year Change
167.19%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since January 10, 2014, GlycoMimetics's market cap has increased from $146.90M to $193.18M, an increase of 31.51%. That is a compound annual growth rate of 2.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 193.40M | -5.66% |
Mar 27, 2024 | 205.00M | 11.72% |
Mar 26, 2024 | 183.50M | 1.05% |
Mar 25, 2024 | 181.60M | -3.76% |
Mar 22, 2024 | 188.70M | 1.73% |
Mar 21, 2024 | 185.50M | -5.55% |
Mar 20, 2024 | 196.40M | 4.08% |
Mar 19, 2024 | 188.70M | 4.66% |
Mar 18, 2024 | 180.30M | 9.41% |
Mar 15, 2024 | 164.80M | -1.96% |
Mar 14, 2024 | 168.10M | 2.38% |
Mar 13, 2024 | 164.20M | -2.67% |
Mar 12, 2024 | 168.70M | 2.37% |
Mar 11, 2024 | 164.80M | -6.26% |
Mar 8, 2024 | 175.80M | -2.50% |
Mar 7, 2024 | 180.30M | -3.43% |
Mar 6, 2024 | 186.70M | - |
Mar 5, 2024 | 186.70M | -4.65% |
Mar 4, 2024 | 195.80M | 1.03% |
Mar 1, 2024 | 193.80M | 4.14% |
Feb 29, 2024 | 186.10M | 0.70% |
Feb 28, 2024 | 184.80M | -4.99% |
Feb 27, 2024 | 194.50M | -1.27% |
Feb 26, 2024 | 197.00M | 5.52% |
Feb 23, 2024 | 186.70M | -1.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Regulus Therapeutics | 186.25M |
Amylyx Pharmaceuticals | 185.72M |
InfuSystem Holdings | 185.47M |
LENZ Therapeutics | 185.19M |
Adicet Bio | 184.02M |
Genfit | 182.89M |
Quipt Home Medical | 181.88M |
Aldeyra Therapeutics | 180.81M |